These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35383141)

  • 1. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
    Wang X; Hu A; Chen X; Zhang Y; Yu F; Yue S; Li A; Zhang J; Pan Z; Yang Y; Lin Y; Gao L; Zhou J; Zhao J; Li F; Shi Y; Huang F; Yang X; Peng Y; Tu L; Zhang H; Zheng H; He J; Zhang H; Xu L; Huang Q; Zhu Y; Deng K; Ye L
    Signal Transduct Target Ther; 2022 Apr; 7(1):114. PubMed ID: 35383141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.
    Wang X; Chen X; Tan J; Yue S; Zhou R; Xu Y; Lin Y; Yang Y; Zhou Y; Deng K; Chen Z; Ye L; Zhu Y
    Cell Host Microbe; 2022 Jun; 30(6):887-895.e4. PubMed ID: 35436443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
    Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
    Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD.
    Errico JM; Zhao H; Chen RE; Liu Z; Case JB; Ma M; Schmitz AJ; Rau MJ; Fitzpatrick JAJ; Shi PY; Diamond MS; Whelan SPJ; Ellebedy AH; Fremont DH
    Cell Rep; 2021 Oct; 37(4):109881. PubMed ID: 34655519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.
    Zhang C; Wang Y; Zhu Y; Liu C; Gu C; Xu S; Wang Y; Zhou Y; Wang Y; Han W; Hong X; Yang Y; Zhang X; Wang T; Xu C; Hong Q; Wang S; Zhao Q; Qiao W; Zang J; Kong L; Wang F; Wang H; Qu D; Lavillette D; Tang H; Deng Q; Xie Y; Cong Y; Huang Z
    Nat Commun; 2021 Jan; 12(1):264. PubMed ID: 33431876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
    Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein.
    Xu S; Wang Y; Wang Y; Zhang C; Hong Q; Gu C; Xu R; Wang T; Yang Y; Zang J; Zhou Y; Li Z; Liu Q; Zhou B; Bai L; Zhu Y; Deng Q; Wang H; Lavillette D; Wong G; Xie Y; Cong Y; Huang Z
    Emerg Microbes Infect; 2022 Dec; 11(1):351-367. PubMed ID: 34964428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.
    Kim JW; Heo K; Kim HJ; Yoo Y; Cho HS; Jang HJ; Lee HY; Ko IY; Woo JR; Cho YB; Lee JH; Yang HR; Shin HG; Choi HL; Hwang K; Kim S; Kim H; Chun K; Lee S
    Antiviral Res; 2023 Apr; 212():105576. PubMed ID: 36870394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
    Lin Y; Yue S; Yang Y; Yang S; Pan Z; Yang X; Gao L; Zhou J; Li Z; Hu L; Tang J; Wu Q; Lei S; Tian Q; Wang Y; Hao Y; Xu L; Huang Q; Zhu B; Chen Y; Chen X; Ye L
    Clin Infect Dis; 2023 Feb; 76(3):e336-e341. PubMed ID: 35666466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
    Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
    Torres JL; Ozorowski G; Andreano E; Liu H; Copps J; Piccini G; Donnici L; Conti M; Planchais C; Planas D; Manganaro N; Pantano E; Paciello I; Pileri P; Bruel T; Montomoli E; Mouquet H; Schwartz O; Sala C; De Francesco R; Wilson IA; Rappuoli R; Ward AB
    Proc Natl Acad Sci U S A; 2022 May; 119(20):e2120976119. PubMed ID: 35549549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
    Fan C; Cohen AA; Park M; Hung AF; Keeffe JR; Gnanapragasam PNP; Lee YE; Gao H; Kakutani LM; Wu Z; Kleanthous H; Malecek KE; Williams JC; Bjorkman PJ
    Immunity; 2022 Dec; 55(12):2419-2435.e10. PubMed ID: 36370711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
    Chu X; Ding X; Yang Y; Lu Y; Li T; Gao Y; Zheng L; Xiao H; Yang T; Cheng H; Huang H; Liu Y; Lou Y; Wu C; Chen Y; Yang H; Ji X; Guo H
    Biochem Biophys Res Commun; 2023 Jun; 660():43-49. PubMed ID: 37062240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein.
    Otsubo R; Minamitani T; Kobiyama K; Fujita J; Ito T; Ueno S; Anzai I; Tanino H; Aoyama H; Matsuura Y; Namba K; Imadome KI; Ishii KJ; Tsumoto K; Kamitani W; Yasui T
    Sci Rep; 2022 Nov; 12(1):20120. PubMed ID: 36418391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
    Li R; Mor M; Ma B; Clark AE; Alter J; Werbner M; Lee JC; Leibel SL; Carlin AF; Dessau M; Gal-Tanamy M; Croker BA; Xiang Y; Freund NT
    Commun Biol; 2022 Aug; 5(1):789. PubMed ID: 35931732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
    Guenthoer J; Lilly M; Starr TN; Dadonaite B; Lovendahl KN; Croft JT; Stoddard CI; Chohan V; Ding S; Ruiz F; Kopp MS; Finzi A; Bloom JD; Chu HY; Lee KK; Overbaugh J
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2220948120. PubMed ID: 37253011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
    Hua RH; Zhang SJ; Niu B; Ge JY; Lan T; Bu ZG
    Microbiol Spectr; 2023 Aug; 11(4):e0119023. PubMed ID: 37306579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain.
    Altomare CG; Adelsberg DC; Carreno JM; Sapse IA; Amanat F; Ellebedy AH; Simon V; Krammer F; Bajic G
    mBio; 2022 Jun; 13(3):e0358021. PubMed ID: 35467422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.